Pharmacologic treatments for covid-19 patients
Febuxostat vs Hydroxychloroquine
This comparison will not be updated. Last search date 28 Feb, 2022.
Outpatients
Forest plots
(last update: 2022-04-29)
To access all information :
- click here for Outpatients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=135
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| IRCT20190727044343N1 Davoodi L, Int J Clin Pract, 2020 Full text Commentary |
Public/non profit |
Febuxostat |
Hydroxychloroquine |
RCT | Outpatients with COVID-19 (mild-moderate) treated at a single center in Iran | N=60 |
Some concerns Details |
|